sorafenib has been researched along with ic 261 in 1 studies
| Studies (sorafenib) | Trials (sorafenib) | Recent Studies (post-2010) (sorafenib) | Studies (ic 261) | Trials (ic 261) | Recent Studies (post-2010) (ic 261) |
|---|---|---|---|---|---|
| 6,520 | 730 | 5,251 | 10 | 0 | 3 |
| Protein | Taxonomy | sorafenib (IC50) | ic 261 (IC50) |
|---|---|---|---|
| Casein kinase I isoform alpha | Homo sapiens (human) | 1.12 | |
| Casein kinase I isoform delta | Homo sapiens (human) | 1.785 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alessi, DR; Arthur, JS; Bain, J; Cohen, P; Elliott, M; Hastie, CJ; Klevernic, I; McLauchlan, H; Plater, L; Shpiro, N | 1 |
1 other study(ies) available for sorafenib and ic 261
| Article | Year |
|---|---|
The selectivity of protein kinase inhibitors: a further update.
Topics: Amino Acid Sequence; Animals; Cell Line; Drug Design; Enzyme Activation; Humans; Mitogen-Activated Protein Kinases; Phosphorylation; Protein Kinase Inhibitors; Recombinant Proteins; Spodoptera | 2007 |